BridgeBio Oncology Therapeutics Inc. ( BBOT) - Key Metrics
BBOT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$705.20 | -$554.14 | -$554.73 |
| 2026Q1 | $0 | -$1.35 | -$1.15 | -$1.15 |
| 2025Q4 | $0 | -$1.25 | -$1.36 | -$1.36 |
| 2025Q3 | $0 | -$1.90 | -$3 | -$3.03 |
| 2025Q2 | $0 | -$1.21 | -$0.99 | -$1 |
BBOT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.00 |
| 2026Q1 | 0% | -1.66 |
| 2025Q4 | 0% | -2.50 |
| 2025Q3 | 0% | -1.52 |
| 2025Q2 | 0% | -2.19 |
BBOT
Price: $9.08
52 week price:
Earnings Per Share: -2.27 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 726.4 million